defessel L, Azuma J, Toh R, Merk DR, Deng A, Chin JT,
et al. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J Clin Invest 2012;122:
497-506.
163. Maegdefessel L, Dalman RL, Tsao PS. Pathogenesis of
abdominal aortic aneurysms: microRNAs, proteases, genetic associations. Annu Rev Med 2014;65:49-62.
164. Zhang W, Shang T, Huang C, Yu T, Liu C, Qiao T, et al. Plasma
microRNAs serve as potential biomarkers for abdominal
aortic aneurysm. Clin Biochem 2015;48:988-92.
165. Cheuk BL, Cheng SW. IdentiÔ¨Åcation and characterization of
microRNAs in vascular smooth muscle cells from patients
with abdominal aortic aneurysms. J Vasc Surg 2014;59:
202-9.
166. Htun NM, Peter K. Biomarkers for AAA: encouraging steps
but clinical relevance still to be delivered. Proteomics Clin
Appl 2014;8:732-4.
167. Moris DN, Georgopoulos SE. Circulating biomarkers for
abdominal aortic aneurysm: what did we learn in the last
decade? Int Angiol 2013;32:266-80.
168. Clifton MA. Familial abdominal aortic aneurysms. Br J Surg
1977;64:765-6.
169. Wahlgren CM, Larsson E, Magnusson PK, Hultgren R,
Swedenborg J. Genetic and environmental contributions to
abdominal aortic aneurysm development in a twin population. J Vasc Surg 2010;51:3-7.
170. Hinterseher I, Tromp G, Kuivaniemi H. Genes and abdominal aortic aneurysm. Ann Vasc Surg 2011;2